Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Fox Chase Cancer Center Welcomes Diagnostic Radiologist Meghan Boros
PHILADELPHIA (November 1, 2018) – Fox Chase Cancer Center is pleased to announce the hiring of Meghan Boros, MD, who will be joining the department of Diagnostic Imaging.
Boros is board-certified in radiology and specializes in breast imaging. She comes to Fox Chase from Southeast Radiology, Ltd. Among many professional achievements, Boros has presented at several national meetings and has publications in both the Journal of Ultrasound in Medicine and the American Peptide Society.
In 2017, Boros completed a one-year breast imaging fellowship at Northwestern University Feinberg School of Medicine. She received training in screening and diagnostic mammography, tomosynthesis, pre-operative needle localizations, breast MRI, and interventional procedures. She received her medical degree from the University of Arizona College of Medicine, and completed a four-year radiology residency at Einstein Medical Center in Philadelphia.
“We are excited to welcome Dr. Boros to our team,” said Rosaleen Parsons, MD, chair of the Department of Diagnostic Imaging at Fox Chase. “Her clinical experience, and research background will be a great addition to Fox Chase.”
Fox Chase Cancer Center’s Department of Diagnostic Imaging plays a vital role in finding, monitoring, and treating cancer and various non-cancerous conditions. Patients get the latest imaging technology in the most experienced hands. The Fox Chase diagnostic imaging team includes board-certified radiologists, nurses, and technologists who expertly and compassionately guide patients through the entire imaging process. If a problem is detected, the institution’s multidisciplinary medical team works together to determine the best course of treatment.
Boros will begin seeing patients at Fox Chase on November 1.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427